706 First-in-human phase 2 clinical trial of multiplex combination intratumoral immunotherapy (MCII) in patients with metastatic solid cancer (Abscopal 5001 trial)

• David G Bostwick,
• Melanie M Wilk,
• Brian R Bostwick,
• Peter M Rydesky,
• Peter J Littrup,
• Michael Cribbs,
• Julie Linton,
• Colleen E Ellis,
• Eugene C Rajaratnam,
• Laura M Galeazzi,
• Junqi Qian

Affiliations

David G Bostwick

1Rampart Health, Orlando, FL, USA

Melanie M Wilk

1Rampart Health, Orlando, FL, USA

Brian R Bostwick

1Rampart Health, Orlando, FL, USA

Peter M Rydesky

2Ascension Providence Rochester Hospital, Rochester, MI, USA

Peter J Littrup

1Rampart Health, Orlando, FL, USA

Michael Cribbs

2Ascension Providence Rochester Hospital, Rochester, MI, USA

Julie Linton

2Ascension Providence Rochester Hospital, Rochester, MI, USA

Colleen E Ellis

2Ascension Providence Rochester Hospital, Rochester, MI, USA

Eugene C Rajaratnam

3Antelope Valley Surgical Institute, Lancaster, CA, USA

Laura M Galeazzi

3Antelope Valley Surgical Institute, Lancaster, CA, USA

Junqi Qian

1Rampart Health, Orlando, FL, USA